SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Saturday 14 November 2026
News from the 24 hours to Saturday morning, 14 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
The only relevant coverage was a piece about the company's share price movement within the FTSE 350, with no clear direction or cause given in the headline.
What drove it
- share price movement
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Mon 9 Nov | +0.8 | 1 |
| Tue 10 Nov | −5.0 | 1 |
| Thu 12 Nov | +0.8 | 5 |
| Fri 13 Nov | −5.7 | 3 |
| Sat 14 Nov | 0.0 | 1 |
1 story · 1 headline · strongest first
Pharma and healthcare on 14 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew market watch commentary +0.31 headline today · 2 in all, since 12 November · A commentary asks why Smith & Nephew is moving within the FTSE 350. | ||
| 0.0 | Share price movement piece with no stated direction or cause in the title. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.